Your browser doesn't support javascript.
loading
Combined Gene Therapy Using AdsVEGFR2 and AdsTie2 With Chemotherapy Reduces the Growth of Human Ovarian Cancer and Formation of Ascites in Mice.
Tuppurainen, Laura; Sallinen, Hanna; Karvonen, Anni; Valkonen, Elina; Laakso, Hanne; Liimatainen, Timo; Hytönen, Elisa; Hämäläinen, Kirsi; Kosma, Veli-Matti; Anttila, Maarit; Ylä-Herttuala, Seppo.
Afiliação
  • Tuppurainen L; *Department of Biotechnology and Molecular Medicine, A. I. Virtanen Institute for Molecular Sciences, and †Institute of Clinical Medicine, Gynecology, and Pathology and Forensic Medicine, University of Eastern Finland; ‡Department of Gynecology, Kuopio University Hospital; §NMR Research Group, A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland; ∥Department of Pathology and ¶Gene Therapy Unit, Kuopio University Hospital; and #Science Service Center, Kuopio University H
Int J Gynecol Cancer ; 27(5): 879-886, 2017 06.
Article em En | MEDLINE | ID: mdl-28498260

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Terapia Genética / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Receptor TIE-2 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Terapia Genética / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Receptor TIE-2 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article